You are a new associateat the law firm of Dewey, Chetum, and Howe. John, a former researcher atPharmaCARE, comes to your office. He has concerns about PharmaCAREsuse of AD23, one of the companys top-selling diabetes drugs.Two (2)years ago, after PharmaCAREs research indicated that AD23 might alsoslow the progression of Alzheimers disease, John and his team ofpharmacists began reformulating the drug to maximize that effect. Inorder to avoid the Food and Drug Administrations (FDA) scrutiny,PharmaCARE established a wholly-owned subsidiary, CompCARE, to operateas a compounding pharmacy to sell the new formulation to individuals on aprescription basis. CompCARE established itself in a suburban officepark near its parents headquarters. To conserve money and time,CompCARE did a quick, low-cost renovation.CompCARE benefited from